In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Heart failure congress sets new record for original science submissions

Heart Failure (HF)


29 April to 2 May in Paris, France

Sophia Antipolis 29 March 2017. A new record for original science submissions has been set for the world’s leading heart failure congress. In addition to the main abstract programme, highly anticipated results from major studies will be presented in the late breaking trial sessions.

Authors from the across the globe sent nearly 2 000 abstracts to the scientific committee of Heart Failure 2017 and the 4th World Congress on Acute Heart Failure. The main annual meeting of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) takes place from 29 April to 2 May at the Palais des Congrès in Paris, France.

The full scientific programme is available: here

“No other meeting has had so much new research presented in heart failure,” said Professor Alexandre Mebazaa, Heart Failure 2017 Scientific Chairperson. “Companies and major academic centres are eager to present results of their latest trials at this congress which is a good sign that it is the place to present new work in this field.”

Controversial issues will be tackled by top cardiologists in the new Grand Debates sessions, giving members of the press both sides of the story. Professor Eugene Braunwald will introduce the first session on LCZ696 (sacubitril/valsartan), and Professor John McMurray and Professor Mariell Jessup will battle out whether it is ready for prime time as first-line therapy.

The 50th anniversary of heart transplantation will be marked with dedicated sessions. Leaders in the field will explore the limits to heart transplantation, present the latest research on immunosuppression and rejection, and ask “Will we ever be able to cure heart failure”?

The congress tagline “rendez-vous with the future” emphasises the 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure1 as the new standard of care and puts the spotlight on young cardiologists, represented by the Heart failure specialists of Tomorrow (HoTs).

“We used to publish guidelines and that was the end of the story,” said Professor Mebazaa. “This year we will give practical examples of how physicians can implement the best knowledge into their daily practice. HoT members will challenge the application of the guidelines – journalists interested in challenging current practice should not miss these sessions.”

The second annual HoT Walk will take place on the evening of Monday 1 May. Members of the public are invited to join the HFA, French Federation of Cardiology, and French Society of Cardiology for a 3 km walk through the streets of Paris.

The HFA Lifetime Achievement Award will be bestowed on two prominent cardiologists during the Inaugural Session and each will give a keynote lecture. In the HFA Philip Poole Wilson Lecture, Professor Faiez Zannad will reveal the next frontier for mineralocorticoid receptor antagonists, while Professor Michel Komajda will devote the HFA Eugene Braunwald Lecture to the topic “Heart failure and diabetes mellitus: les liaisons dangereuses”.

ESC Gold Medalist and cardiac surgery pioneer Professor Alain Carpentier will talk about the total artificial heart he invented in the session “Allez les Bleus! Groundbreaking French contributions to cardiology”.

Professor Mebazaa said: “This is the event of the year in heart failure and members of the media should mark their calendars. The World Congress on Acute Heart Failure will showcase novel results from large trials on new drugs. Heart Failure 2017 will give the state-of-the-art on the hot topic of preventing heart failure, as research has shown that the heart’s malfunction leads to many other diseases. We will also hear the latest findings on treating women and men, who we now know need tailored therapies.”

Some 6 000 delegates are set to attend the four day event which features 120 scientific sessions. Journalists are highly recommended to register now.

ENDS

Notes to editor

ESC Press Office
Tel: +33 (0) 4 89 87 34 83
Email: press@escardio.org

About Heart Failure 2017 and the 4th World Congress on Acute Heart Failure
Heart Failure is the annual congress of the Heart Failure Association of the ESC. The 4th World Congress on Acute Heart Failure is part of the main programme of Heart Failure 2017.

About the Heart Failure Association
The Heart Failure Association (HFA) is a registered branch of the ESC. Its aim is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.

About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 140 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

Information for journalists attending Heart Failure 2017
Heart Failure 2017 takes place 29 April to 2 May in Paris, France at the Palais des Congrès.
The full scientific programme is available here
Free registration applies to press representatives. Get accredited and register: here